Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q7ZQ
|
|||
| Former ID |
DAP001132
|
|||
| Drug Name |
Succinylcholine
|
|||
| Synonyms |
Anectine; Diacetylcholine; Ditilin; Ditiline; Listenon; Lysthenon; Quelicin; SCK; Succicuran; Succinocholine; Succinoylcholine; Succinylbischoline; Succinyldicholine; Sucostrin; Suxamethonium; Dicholine succinate; Succinyl choline; Anectine (TN); Scoline (TN); Succinic acid, diester with choline; Succinic acid, diester with choline chloride; Choline, succinate (ester); Choline, succinate (2:1) (ester); Trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio; Trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium; 2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Spasm [ICD-11: MB47.3; ICD-10: R25.2; ICD-9: 338,780] | Approved | [1], [2], [3] | |
| Therapeutic Class |
Analgesics
|
|||
| Company |
Sandoz Canada Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H30N2O4+2
|
|||
| Canonical SMILES |
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
|
|||
| InChI |
1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2
|
|||
| InChIKey |
AXOIZCJOOAYSMI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 306-40-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9749, 7658696, 7672825, 7980692, 8153258, 11111825, 12075317, 14710537, 14873361, 15047415, 26744180, 29224368, 46506023, 47515447, 49903255, 50111236, 53812664, 53812668, 57322704, 57820299, 77403683, 81065590, 85209629, 90341285, 92309310, 103194169, 103957129, 104308882, 114917406, 118518886, 124750220, 124752895, 124881499, 124881500, 126408127, 127473514, 134338377, 134974288, 137004055, 141317082, 144035335, 152198910, 160963550, 175265529, 175442114, 176484556, 178100830, 179116901, 215683529, 226426545
|
|||
| ChEBI ID |
CHEBI:45652
|
|||
| ADReCS Drug ID | BADD_D02079 ; BADD_D02080 | |||
| SuperDrug ATC ID |
M03AB01
|
|||
| SuperDrug CAS ID |
cas=000306401
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4004). | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 008453. | |||
| REF 4 | The involvement of histaminic and muscarinic receptors in the bronchoconstriction induced by myorelaxant administration in sensitized rabbits. Anesth Analg. 2008 Dec;107(6):1899-906. | |||
| REF 5 | Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology. 1998 Mar;88(3):744-50. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.